Intracranial bleeding in acute promyelocytic leukemia treated with arsenic trioxide based regimens is associated with induction mortality but not with relapse
Open Access
- 22 June 2023
- journal article
- letter
- Published by Springer Nature in Blood Cancer Journal
- Vol. 13 (1) , 1-3
Abstract
No abstract availableKeywords
Funding Information
- DBT India Alliance (IA/CPHE/17/1/503351, IA/S/15/1/501842, IA/CPHS/18/1/503930)
This publication has 4 references indexed in Scilit:
- Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemiaBlood Cancer Journal, 2022
- Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimensBritish Journal of Haematology, 2020
- Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up DataJournal of Clinical Oncology, 2010
- Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxisHaematologica, 2009